Article
Efficacy and safety of genotype-guided antiplatelet therapy versus standard treatment in 4,604 patients with CAD after PCI: a meta-analysis of randomized controlled trials.
Die Pharmazie - 1 Dec 2020
Liu Di, Zhao Li Yun, Wu Hui, Zhou Gang, Yang Jun, Yang Jian, Ding Jia Wang, Fan Zhi Xing, Yang Chao Jun
Abstract excerpt
Objective: To compare the efficacy and safety of genotype-guided antiplatelet strategy and standard treatment in patient with coronary artery disease (CAD) after percutaneous coronary intervention (PCI). Methods: Relevant studies published in Medline, Embase, CoChrane Library were searched for randomized controlled trials (RCTs) until August 2020. Studies were screened by selection criteria, quality assessed...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
